INF2 Mutations in Charcot-Marie-Tooth Disease with Glomerulopathy

被引:212
作者
Boyer, Olivia [1 ,4 ,11 ]
Nevo, Fabien [1 ,11 ]
Plaisier, Emmanuelle [2 ,7 ,12 ]
Funalot, Benoit [16 ,17 ,18 ]
Gribouval, Olivier [1 ,11 ]
Benoit, Genevieve [1 ,26 ]
Cong, Evelyne Huynh [1 ,11 ]
Arrondel, Christelle [1 ,11 ]
Tete, Marie-Josephe [1 ,11 ]
Montjean, Rodrick [1 ,11 ]
Richard, Laurence [16 ,17 ,18 ]
Karras, Alexandre [8 ,11 ]
Pouteil-Noble, Claire [19 ,20 ]
Balafrej, Leila [28 ]
Bonnardeaux, Alain [27 ]
Canaud, Guillaume [5 ,11 ]
Charasse, Christophe [22 ]
Dantal, Jacques [23 ]
Deschenes, Georges [9 ,13 ]
Deteix, Patrice [24 ]
Dubourg, Odile [10 ]
Petiot, Philippe [21 ]
Pouthier, Dominique [29 ]
Leguern, Eric [3 ,12 ,14 ]
Guiochon-Mantel, Anne [25 ]
Broutin, Isabelle [11 ,15 ]
Gubler, Marie-Claire [1 ,11 ]
Saunier, Sophie [1 ,11 ]
Ronco, Pierre [2 ,7 ,12 ]
Vallat, Jean-Michel [16 ,17 ,18 ]
Angel Alonso, Miguel [30 ]
Antignac, Corinne [1 ,6 ,11 ]
Mollet, Geraldine [1 ,11 ]
机构
[1] Hop Necker Enfants Malad, AP HP, INSERM, U983, F-75015 Paris, France
[2] Hop Necker Enfants Malad, AP HP, Unite 702, F-75015 Paris, France
[3] Hop Necker Enfants Malad, AP HP, Unite 975, F-75015 Paris, France
[4] Hop Necker Enfants Malad, AP HP, Serv Nephrol Pediat, F-75015 Paris, France
[5] Hop Necker Enfants Malad, AP HP, Serv Transplantat & Soins Intensifs, F-75015 Paris, France
[6] Hop Necker Enfants Malad, AP HP, Serv Genet, F-75015 Paris, France
[7] Hop Tenon, AP HP, Serv Nephrol & Dialyses, F-75970 Paris, France
[8] Hop Europeen Georges Pompidou, AP HP, Serv Nephrol, Paris, France
[9] Hop Robert Debre, AP HP, Serv Nephrol Pediat, F-75019 Paris, France
[10] Hop La Pitie Salpetriere, AP HP, Inst Myol, Paris, France
[11] Univ Paris 05, Paris, France
[12] Univ Paris 06, Paris, France
[13] Univ Paris Diderot, Paris, France
[14] CNRS, Unite 7225, Paris, France
[15] Lab Cristallog & RMN Biol, Paris, France
[16] CHU, Lab Neurol, Limoges, France
[17] CHU, Serv Neurol, Limoges, France
[18] Univ Limoges, Limoges, France
[19] Univ Lyon, Lyon, France
[20] Ctr Hosp Lyon Sud, Serv Nephrol, Lyon, France
[21] Hop Croix Rousse, Serv Neurol, F-69317 Lyon, France
[22] Ctr Hosp St Brieuc, St Brieuc, France
[23] CHU Hotel Dieu, Serv Nephrol & Immunol Clin, Nantes, France
[24] Univ Auvergne, CHU Gabriel Montpied, Clermont Ferrand, France
[25] Univ Paris 11, CHU Bicetre, Le Kremlin Bicetre, France
[26] Univ Montreal, CHU St Justine, Serv Nephrol Pediat, Montreal, PQ, Canada
[27] Hop Maison Neuve Rosemont, Ctr Rech Guy Bernier, Montreal, PQ H1T 2M4, Canada
[28] Ctr Nephrol & Hemodialyse Riad, Rabat, Morocco
[29] Ctr Hosp Luxembourg, Serv Nephrol, Luxembourg, Luxembourg
[30] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, Madrid, Spain
关键词
MEDIATED TRANSPORT; EPITHELIAL-CELLS; MYELIN; PROTEIN; FORMIN; GENE; RHO; GLOMERULOSCLEROSIS; NEPHROPATHY; NEUROPATHY;
D O I
10.1056/NEJMoa1109122
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Charcot-Marie-Tooth neuropathy has been reported to be associated with renal diseases, mostly focal segmental glomerulosclerosis (FSGS). However, the common mechanisms underlying the neuropathy and FSGS remain unknown. Mutations in INF2 were recently identified in patients with autosomal dominant FSGS. INF2 encodes a formin protein that interacts with the Rho-GTPase CDC42 and myelin and lymphocyte protein (MAL) that are implicated in essential steps of myelination and myelin maintenance. We therefore hypothesized that INF2 may be responsible for cases of Charcot-Marie-Tooth neuropathy associated with FSGS. METHODS We performed direct genotyping of INF2 in 16 index patients with Charcot-Marie-Tooth neuropathy and FSGS who did not have a mutation in PMP22 or MPZ, encoding peripheral myelin protein 22 and myelin protein zero, respectively. Histologic and functional studies were also conducted. RESULTS We identified nine new heterozygous mutations in 12 of the 16 index patients (75%), all located in exons 2 and 3, encoding the diaphanous-inhibitory domain of INF2. Patients presented with an intermediate form of Charcot-Marie-Tooth neuropathy as well as a glomerulopathy with FSGS on kidney biopsy. Immunohistochemical analysis revealed strong INF2 expression in Schwann-cell cytoplasm and podocytes. Moreover, we demonstrated that INF2 colocalizes and interacts with MAL in Schwann cells. The INF2 mutants perturbed the INF2-MAL-CDC42 pathway, resulting in cytoskeleton disorganization, enhanced INF2 binding to CDC42 and mislocalization of INF2, MAL, and CDC42. CONCLUSIONS INF2 mutations appear to cause many cases of FSGS-associated Charcot-Marie-Tooth neuropathy, showing that INF2 is involved in a disease affecting both the kidney glomerulus and the peripheral nervous system. These findings provide new insights into the pathophysiological mechanisms linking formin proteins to podocyte and Schwanncell function. (Funded by the Agence Nationale de la Recherche and others.)
引用
收藏
页码:2377 / 2388
页数:12
相关论文
共 50 条
  • [31] Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy
    Claeys, Kristl G.
    Zuechner, Stephan
    Kennerson, Marina
    Berciano, Jose
    Garcia, Antonio
    Verhoeven, Kristien
    Storey, Elsdon
    Merory, John R.
    Bienfait, Henriette M. E.
    Lammens, Martin
    Nelis, Eva
    Baets, Jonathan
    De Vriendt, Els
    Berneman, Zwi N.
    De Veuster, Ilse
    Vance, Jefferey M.
    Nicholson, Garth
    Timmerman, Vincent
    De Jonghe, Peter
    BRAIN, 2009, 132 : 1741 - 1752
  • [32] Drosophila Charcot-Marie-Tooth Disease Models
    Yamaguchi, Masamitsu
    Takashima, Hiroshi
    DROSOPHILA MODELS FOR HUMAN DISEASES, 2018, 1076 : 97 - 117
  • [33] Mutation screening of mitofusin 2 in Charcot-Marie-Tooth disease type 2
    McCorquodale, Donald S., III
    Montenegro, Gladys
    Peguero, Ainsley
    Carlson, Nicole
    Speziani, Fiorella
    Price, Justin
    Taylor, Sean W.
    Melanson, Michel
    Vance, Jeffery M.
    Zuechner, Stephan
    JOURNAL OF NEUROLOGY, 2011, 258 (07) : 1234 - 1239
  • [34] Certification of a Pilot with Charcot-Marie-Tooth Disease
    Jagathesan, Tania
    O'Brien, Michael
    Rattray, Alexander
    AEROSPACE MEDICINE AND HUMAN PERFORMANCE, 2021, 92 (02) : 124 - 126
  • [35] Audiological findings in the Charcot-Marie-Tooth Disease
    Fukushima, Erika
    Sens, Patricia Maria
    Lambert, Ernani
    BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2011, 77 (01) : 135 - 135
  • [36] Current Issues of the Charcot-Marie-Tooth Disease
    Choi, Byung-Ok
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2007, 50 (05): : 457 - 463
  • [37] Precision Medicine for Charcot-Marie-Tooth Disease
    Pleasure, David
    JAMA NEUROLOGY, 2016, 73 (06) : 623 - 624
  • [38] Disease Progression in Charcot-Marie-Tooth Disease Related to MPZ Mutations: A Longitudinal Study
    Fridman, Vera
    Sillau, Stefan
    Bockhorst, Jacob
    Smith, Kaitlin
    Moroni, Isabella
    Pagliano, Emanuela
    Pisciotta, Chiara
    Piscosquito, Guiseppe
    Laura, Matilde
    Muntoni, Francesco
    Bacon, Chelsea
    Feely, Shawna
    Grider, Tiffany
    Gutmann, Laurie
    Shy, Rosemary
    Wilcox, Janel
    Herrmann, David N.
    Li, Jun
    Ramchandren, Sindhu
    Sumner, Charlotte J.
    Lloyd, Thomas E.
    Day, John
    Siskind, Carly E.
    Yum, Sabrina W.
    Sadjadi, Reza
    Finkel, Richard S.
    Scherer, Steven S.
    Pareyson, Davide
    Reilly, Mary M.
    Shy, Michael E.
    ANNALS OF NEUROLOGY, 2023, 93 (03) : 563 - 576
  • [39] Charcot-Marie-Tooth Disease Complicating Type 2 Diabetes
    Win, Htet Htet Ne
    Davenport, Colin
    Delaney, Siobhan
    Kelly, Margaret
    Smith, Diarmuid
    JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 2011, 101 (04) : 349 - 352
  • [40] Clinical and genetic features of Charcot-Marie-Tooth disease patients with IGHMBP2 mutations
    Liu, Lei
    Lin, Zhiqiang
    Li, Xiaobo
    Hu, Zhengmao
    Huang, Shunxiang
    Zhao, Huadong
    Tang, Beisha
    Zhang, Ruxu
    NEUROMUSCULAR DISORDERS, 2022, 32 (07) : 564 - 571